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Introduction: The purpose of this study was to
compare the cell viability of dental pulp cells treated
with Biodentine (Septodont, Saint-Maur, France) and
mineral trioxide aggregate (MTA) and the in vitro
and in vivo expression of mineralization markers
induced by the 2 materials. Methods: Human dental
pulp cells isolated from 6 permanent teeth were stimu-
lated with Biodentine and MTA extracts. Cell viability
was determined using the 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyl tetrazolium bromide assay, and quantita-
tive reverse-transcriptase polymerase chain reaction
was used to determine the expression of mineralization
markers. Specimens of teeth from dogs treated with Bio-
dentine and MTA after pulpotomy were used to deter-
mine the presence of osteopontin and alkaline
phosphatase by immunohistochemistry and runt-
related transcription factor 2 by immunofluorescence.
Results: No significant differences in cell viability
were found between MTA and Biodentine extracts and
controls after 24 and 48 hours (P > .05). After 48 hours,
osteopontin (SPP1), alkaline phosphatase (ALP), and
runt-related transcription factor 2 (RUNX2) expression
was higher in MTA and Biodentine than in controls
(P < .05). Osteopontin staining was more intense and
spread over a greater number of areas in Biodentine
than in MTA samples (P < .0001). Alkaline phosphatase
staining of a mineralized tissue bridge was significantly
different between materials (P < .0001), but no differ-
ence in alkaline phosphatase staining of pulp tissue
was found between MTA and Biodentine (P = .2).
Also, no significant difference in the number of cells
labeled for runt-related transcription factor 2 by immu-
nofluorescence was observed between materials
(P > .05). Conclusions: Biodentine stimulated similar
markers as MTA, but staining was more intense and
spread over a larger area of the pulp tissue. (J Endod
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Mineral trioxide aggregate (MTA) (ProRoot MTA; Dentsply Tulsa Dental, JohnsonCity, TN) has been extensively used in endodontics to protect pulp tissue after pul-
potomy for carious and traumatic exposures. Biodentine (Septodont, Saint-Maur,
France) is a novel root-end filling material, which is a powder consisting mainly of tri-
calcium silicate (Ca3SiO5), zirconium oxide, and calcium carbonate and the mixing
liquid is composed of water, calcium chloride, and a hydrosoluble polymer (1). Similar
toMTA, Biodentine has been shown to release calcium hydroxide (2), induce reparative
dentin synthesis (3), and have antibacterial activity (4). Biodentine offers an additional
advantage over MTA in that it can be used as a temporary enamel substitute and perma-
nent dentin substitute (5). Because this new material comes in contact with both pulp
and periapical tissues, biocompatibility is crucial (6).
Biodentine has shown tissue compatibility and exhibited tissue bridge formation
similar to that of MTA (7). Human clinical cases using Biodentine for conservative and
radical endodontic treatments showed satisfactory results regarding the induction
of mineralization (8–10). However, the differentiation of pulp cells into
odontoblastlike cells (11) and the mineralization (3, 12) induced by this material
are not fully known.
Osteopontin (gene name SPP1), alkaline phosphatase (gene name ALPL), bone
sialoprotein (gene name IBSP), dentin sialophosphoprotein (gene name DSPP), and
dentin matrix protein 1 (gene name DMP1) have been used as markers of differentia-
tion in osteoblasts and odontoblasts to investigate the mechanisms of mineralization
(13–16). Alkaline phosphatase is found in the early stages of osteoblast and
odontoblast differentiation and provides inorganic phosphate to form hydroxyapatite
(ie, the first step of mineralization) (17). Osteopontin is an extracellular matrix acidic
glycoprotein that has been implicated in many physiological and pathological events,
including the maintenance or reconfiguration of tissue integrity during inflammatory
processes (18). The runt-related transcription factor 2 (gene name RUNX2) has
been linked to bone and dental mineralization and plays a primary role in the differen-
tiation of osteoblasts and homeostasis of mineralized tissues (19, 20).
However, further in vivo studies with Biodentine are needed to elucidate the
mechanism of action for biostimulation because differences have been reported be-
tween Biodentine and MTA. Thus, this study aimed to compare the cell viability of dental
pulp cells treated with Biodentine and MTA and the expression of mineralization
markers in vitro and in vivo induced by both materials.o Preto, and †Universidade de S~ao Paulo, Departamento de Analises Clınicas, Toxicologicas e Bro-
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Explant Cell Culture
Teeth extracted for orthodontic reasons were obtained after
informed patient consent (n = 6) and under institutional review board
approval (process # 25315013.0.0000.5419). Human dental pulp cells
were isolated from collected teeth and grown in medium consisting of
Dulbecco’s Modified Eagle’s medium (DMEM) supplemented with 10%
fetal bovine serum, 1% penicillin/streptomycin, and amphotericin. Cells
from the third through fifth passages were used for experimentation.
Preparation of Materials
This study is in accordance with ISO 10993-5:2009 (21). The
extraction method was used to put the materials (Table 1) in contact
with the cells tested. Two cylindric matrices 10 mm in diameter and
5 mm in height were prepared from metallic matrix bands. The mate-
rials were mixed according to the manufacturer’s instructions on a ster-
ile glass slab in a laminar flow cabinet and introduced into the sterile
matrices using sterile instruments for a volume of 47.5 mm3.
The material prepared was kept in the laminar flow cabinet under
ultraviolet light for 1 hour from the initial setting and then placed sepa-
rately in polypropylene tubes with 5 mL incomplete DMEMmedium and
stored refrigerated for 72 hours before the experiment. The remaining
material was discarded; the extracts were filtered, and 1:10 and 1:100
serial dilutions were prepared from the initial extracts (1:1). The 1:1,
1:10, and 1:100 solutions were stored refrigerated until use.
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium
Bromide Assay: Cell Viability
1 105 cells/well were plated in a 96-well plate, preincubated for
12 hours in serum-free media, and then treated with different MTA and
Biodentine extracts for 24 and 48 hours. A tetrazolium dye 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (0.5 mg/mL,
Sigma M-5655 MTT Colorimetric Assay; Sigma-Aldrich, St Louis, MO)
was added to each well and incubated at 37C for 3 hours in the
dark. The absorbance in each well was determined at 570 nm using
a microplate reader (mQuanti; Bio-tek Instruments, Inc, Winooski,
VT). Cell viability in each group was expressed as a percentage and
compared with the control group (culture medium). Data were
analyzed using 1-way analysis of variance followed by the Bonferroni
post test (a = 0.05).
Quantitative Reverse-transcriptase Polymerase Chain
Reaction: Expression of Mineralization-related Genes
SPP1, IBSP, DSPP, ALPL, DMP1, and RUNX2messenger RNA levels
were assayed by quantitative reverse-transcriptase chain reaction using
fluorescent markers. After stimulation with MTA and Biodentine ex-
tracts, cells were harvested for the extraction of total RNA by the column
method using thiocyanate guanidine (RNEasy; Qiagen Inc, Valencia, CA)
according to the manufacturer’s instructions. Total RNA was estimatedTABLE 1. Composition and Manufacturer (city and country) of Materials Evaluate
Brand name Material
Biodentine Powder: tricalcium silicate, dicalcium silicate
carbonate, calcium oxide, iron oxide, zirc
Liquid: calcium chloride, hydrosoluble polym
ProRoot MTA White Powder: Portland cement (75%), bismuth ox
sulfate dihydrate (5%), tricalcium silicate,
tricalcium aluminate, tetracalcium alumin
Liquid: water
2 Daltoe et al.using 2 mL of each sample with a Nanodrop spectrophotometer
(Thermo Scientific, Wilmington, DE).
Next, reverse transcription was performed for complementary
DNA synthesis followed by polymerase chain reaction. Primers and
probes for SPP1 (Hs00959010_m1), IBSP (Hs00173720_m1),
DSPP (Hs00171962_m1), ALPL (Hs01029144_m1), RUNX2
(Hs00231692_m1), and DMP1 (Hs01009391_g1) were obtained
commercially and are proprietary; thus, sequences are not available
(TaqMan Gene Expression Assay; Applied Biosystems, Foster City,
CA). Glyceraldehyde-3-phosphate dehydrogenase (Hs 02758991_g1)
and beta-actin (Hs 01060665_g1) were used as reference genes. Quan-
titative reverse-transcriptase polymerase chain reactions were per-
formed in duplicate using a StepOne Plus real-time PCR system
(Applied Biosystems).
Amplification was performed under the following conditions: acti-
vation of AmpliTaq Gold Enzyme (Applied Biosystems) at 95C for 2 mi-
nutes followed by 40 cycles at 95C for 1 second for DNA denaturation
and 60C for 20 seconds for primer annealing and polymerization. The
results were analyzed based on cycle threshold values. Distilled deion-
ized water was used as a negative control of each primer probe pair.
Relative expression was calculated based on the equation 2DDCt.
Relative messenger RNA expression was compared among the
groups using 1-way analysis of variance followed by the Tukey test
(a = 0.05).
Acquisition of Slides after In Vivo Pulpotomy
The slides used in this section were obtained from the specimen
database at the Children’s Clinic Department, School of Dentistry of
Ribeir~ao Preto, University of S~ao Paulo, Brazil, in accordance with
ISO 7405:2008 (22). This study was approved by the Institutional An-
imal Research Ethics Committee (process #2013.1.643.58.5).
In total, 87 specimens of the upper second and third premolars
and the lower second, third, and fourth premolars from four 12-
month-old male and female Beagle dogs treated with MTA (n = 35)
and Biodentine (n = 52) were evaluated 120 days after pulpotomy.
Immunohistochemistry: In Vivo Osteopontin
and Alkaline Phosphatase Staining
To determine the expression of mineralization-related markers,
immunohistochemistry assays for osteopontin and alkaline phospha-
tase were conducted in the Biodentine (n = 46) and MTA (n = 29)
groups.
The slides were deparaffinized, hydrated in a decreasing ethanol
series, and kept in phosphate-buffered saline (PBS). Next, tissue sec-
tions were microwaved (7 12 seconds at 2-minute intervals) with so-
dium citrate buffer (pH = 6.0) for antigen retrieval. After temperature
stabilization, the slides were washed with PBS (3) for 5 minutes, and
endogenous peroxidase activity was blocked with 3% hydrogen
peroxide for 40 minutes. Slides were further washed with PBS (3)
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Figure 1. (A and B) The effect of Biodentine and MTA concentration on cell viability in primary culture of dental pulp cells by the 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyl tetrazolium bromide assay after 24 and 48 hours. Gene expression of osteopontin (SPP1), alkaline phosphatase (ALPL), and runt-related transcription
factor 2 (RUNX2) compared with the control group after (C, E, and G) 24 and (D, F, and H) 48 hours. Significant differences to the control group (cells incubated
with culture medium only) are indicated by * (P < .05). Independent experiments (n = 2) were done in triplicate.
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bovine serum albumin (Sigma-Aldrich) for 60 minutes. The tissues
were then incubated with primary antibodies for osteopontin
(ab8448, rabbit polyclonal; Abcam, Cambridge, MA) and alkaline
phosphatase (ab54778, mouse monoclonal, Abcam) at 4C overnight.
Next, slides were washed and incubated with antimouse or antirabbit
biotinylated secondary antibodies for 1 hour, washed in PBS, and incu-
bated with streptavidin conjugated with horseradish peroxidase for
20 minutes; 3,30-diaminobenzidine (Sigma-Aldrich) was used as the
enzyme substrate for 5minutes. The slides were washed with PBS, coun-
terstained with Harris’s hematoxylin for 15 seconds, washed with
distilled water, dehydrated in increasing ethanol concentrations, and
mounted in Entellan (Merck, Darmstadt, Germany). Control slides in
which the primary antibody was omitted were used to test the specificity
of immunostaining.
Osteopontin and alkaline phosphatase staining in the mineralized
tissue bridge and pulp tissue was scored (1: mild, 2: moderate, and 3:
intense) at the apical, middle, and cervical root canal thirds. For this
analysis, all slides were prepared in the same batch to obtain a standard-
ized staining and were evaluated by an experienced blind examiner. The
data were converted into percentage, and groups were compared using
the chi-square test (a = 0.05).Indirect Immunoﬂuorescence: Runt-related
Transcription Factor 2 Labeling
To determine the expression of runt-related transcription
factor 2 and its role in the synthesis of mineralization proteinsFigure 2. Photomicrographs showing dentin bridge formation within the cervical d
10 (A), 20 (B and C), and 40 (D) magnification.
4 Daltoe et al.and as an indicator of cell differentiation, indirect immunofluo-
rescence assays were conducted in the Biodentine (n = 6) and
MTA (n = 6) groups.
The slides were prepared as described previously. Next, the
slides were washed with PBS (3) for 5 minutes and 1 mg/mL sodium
borohydride solution (3) (Dina^mica Quımica Contempora^nea Ltda,
Diadema, SP, Brazil) for 15 minutes. Nonspecific binding sites were
blocked with 5% bovine serum albumin (Sigma-Aldrich) for 60 mi-
nutes. Immunolabeling was performed using primary antibody for
runt-related transcription factor 2 (ab23981, rabbit polyclonal, Ab-
cam) at 4C overnight. The following day, the slides were washed in
PBS (3) and incubated with secondary antibody (antirabbit immu-
noglobulin G conjugated with fluorescein) for 1 hour in a dark cham-
ber. The slides were further washed with PBS (3), and the nuclei
were stained with 40,6-diamidino-2-phenylindole (0.5 mg/mL) (Santa
Cruz Biotechnology Inc, Dallas, TX) for 5 minutes. Slides were
mounted with ProLong Gold Antifade (Molecular Probes Inc, Eugene,
OR). The percentage of positively stained cells was determined in the
layer adjacent to the newly formed mineralized tissue, the intact odon-
toblastic layer of pulp tissue, and cells within the central region of this
tissue. First, the regions were photographed by fluorescence micro-
scopy at 20 magnification using Alexa Fluor (Carl Zeiss, G€ottingen,
Germany) and 40,6-diamidino-2-phenylindole filters. Next, the images
were analyzed using ImageJ software (National Institutes of Health,
Bethesda, MD) to determine the number of positively stained cells
by selecting the ‘‘analyze particles’’ tool; pixel size was set as the
average size of previously measured cell nuclei. The total cell countental root canal in teeth treated with (A and C) Biodentine and (B and D) MTA.
JOE— Volume-, Number-,- 2016
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and stained cell count were expressed as a percentage, and staining
was compared across groups using the Tukey test (a = 0.05).
Results
In Vitro
Cell viability was significantly lower in 1:1 and 1:10 MTA and Bio-
dentine extracts than in controls at 24 and 48 hours (P < .05, Fig. 1A
and B). Conversely, cell viability was not affected by 1:100 dilutions, and
no significant differences were found between 1:100 MTA and Bio-
dentine extracts and controls after 24 and 48 hours (P > .05, Fig. 1A
and B). Because cell viability was not affected by 1:100 dilutions, this
concentration was used for the following experiment.
After 24 hours of stimulation, MTA and Biodentine did not modu-
late SPP1, ALPL, and RUNX2 compared to controls (P > .05, Fig. 1C, E,
and G). Conversely, MTA and Biodentine induced higher SPP1, ALPL,
and RUNX2 gene expression than controls at 48 hours (P < .05,Figure 3. Photomicrographs showing osteopontin staining at cervical, middle, and
and F) MTA. Staining of the dentin bridge was detected in more samples and was m
samples compared with MTA. 5 (A), 10 (B, E, and F), and 40 (C and D) m
JOE — Volume-, Number-,- 2016Fig. 1D, F, and H). No IBSP, DSPP, and DMP1 expression was detected
in either experimental period.Mineralization and In Vivo Osteopontin and Alkaline
Phosphatase Staining
Biodentine and MTA induced mineralized tissue formation within
the cervical third of the dental root canal pulp (Fig. 2A–D). We inves-
tigated mineralizing proteins that could be involved in this process.
Osteopontin staining of the mineralized tissue bridge and adjacent
areas was significantly different between the Biodentine and MTA
groups (P < .0001). Mild staining was observed in 29% of MTA cases,
whereas mild, moderate, and intense staining was observed in 26%,
43%, and 22% of Biodentine cases, respectively (Fig. 3).
Alkaline phosphatase staining of the mineralized tissue bridge was
significantly different between fillingmaterials (P< .0001). Mild staining
was found in 14% of MTA cases and 48% of Biodentine cases (Fig. 4).apical root canal thirds in teeth treated with (A, C, and E) Biodentine and (B, D,
ore intense and extended to the apical third of root canal pulp in Biodentine
agnification.
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Figure 4. Photomicrographs showing alkaline phosphatase staining at cervical, middle, and apical root canal thirds in teeth treated with (A, C, and E) Biodentine
and (B, D, and F) MTA. Mild staining of the dentin bridge and intense staining of the entire root dental pulp were detected for either Biodentine or MTA. 10 (A, B,
E, and F) and 20 (C and D) magnification.
Basic Research—BiologyOsteopontin and alkaline phosphatase staining was also evaluated
in pulp tissue at the apical, middle, and cervical root canal thirds. Os-
teopontin staining was significantly different between MTA and Bio-
dentine (P < .0001) and was concentrated at the cervical third in the
2 groups. For MTA, no staining was observed in 57% of cases and
29% of cases were labeled at the cervical and middle thirds, but no
staining was observed at the apical third. No staining was observed in
39% of Biodentine cases, 52% of cases were stained at the cervical third,
and 26% at the middle and apical thirds (Fig. 3A–F).
No significant difference in alkaline phosphatase staining of pulp
tissue was found between MTA and Biodentine (P = .2). High staining
intensity was observed at all root canal thirds in the 2 groups; 100% of
MTA cases were stained at the cervical and middle thirds and 86% at the
apical third, whereas 96% of Biodentine cases were stained at the cer-
vical third and 91% at the middle and apical thirds (Fig. 4A–F).
In Vivo Runt-related Transcription Factor 2
Immunoﬂuorescence
No significant difference was found between Biodentine and MTA
in the number of positively labeled cells by fluorescence in the central6 Daltoe et al.portion of the pulp tissue (Biodentine: 67.3%, MTA: 61.7%; P > .05,
Fig. 5E–H) and the intact odontoblastic layer (Biodentine: 68.7%,
MTA: 67%; P > .05, Fig. 5I–L). Similarly, no significant difference
was found in the number of positively stained cells in the region adjacent
to newly formedmineralized tissue between Biodentine (87%) andMTA
(58%) (P > .05, Fig. 5A–D).Discussion
Studies comparing the cell viability of Biodentine and MTA have
shown the similarity between the 2 materials (23–27). Those results
are in agreement with the findings of this study, which showed that
Biodentine and MTA had a similar effect on cell viability. In addition
to maintaining cell viability, capping materials must be able to induce
the formation of mineralized tissue bridges when in contact with pulp
tissue in procedures such as pulpotomies and pulp capping
treatments. SPP1 and RUNX2 were stimulated in this study in
agreement with a previous study (14), indicating that these genes
may play an early role in the mineralization process and their long-
term maintenance.JOE— Volume-, Number-,- 2016
Figure 5. Fluorescence microscopic images showing runt-related transcription factor 2 in teeth treated with (B, D, G, H, K, and L) Biodentine and (A, C, E, F, I,
and J) MTA using Alexa Fluor and DAPI filters. Similar green fluorescence was observed for the 2 materials in the (A–D) mineralized tissue bridge, (E–H) pulp
center, and (I–L) odontoblastic layer. 10 (A–D) and 40 (E–L) magnification.
Basic Research—BiologyAlkaline phosphatase activity is required for mineral deposition in
dentinal collagen sheets (28). In this study, staining was diffuse and
extracellular, which is in agreement with other studies that suggested
that alkaline phosphatase plays a role in the organism’s reaction toJOE — Volume-, Number-,- 2016injury. Increased ALPL gene expression in vitro has also been observed
in other studies after MTA and Biodentine stimulation (29–31).
Conversely, decreased alkaline phosphatase expression with
simultaneous reduction in enzyme activity has been shown afterExpression of Mineralization Markers 7
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11 days of culture, which may be indicative of osteoblast maturation,
thus supporting the involvement of this marker in initial
mineralization (11).
Increased SPP1 gene expression was also shown in vitro after Bio-
dentine and MTA stimulation in a previous study with no difference be-
tween materials (14), which is in line with the current findings. The
presence of osteopontin was also investigated by immunohistochem-
istry in a pulp capping study with calcium hydroxide, MTA, and Bio-
dentine in a rat pulp injury model. The dentin bridge was strongly
positive for osteopontin in all samples, whereas adjacent cells showed
weak staining in the calcium hydroxide group andmore intense staining
in the MTA and Biodentine groups (32). Similar results were observed
in this study, but osteopontin staining was more intense and spread over
a greater number of areas in Biodentine samples. To date, no study had
shown such broad osteopontin expression extending to the apical pulp.
The RUNX2 gene coordinates multiple signaling pathways related
to osteoblastic differentiation (33), odontoblastic differentiation (34),
and tooth development (35). Increased RUNX2 gene expression
in vitro was detected in this study and similar findings have been re-
ported previously (14). After longer experimental periods the same
pattern of RUNX2 expression induced by both capping materials has
also been shown elsewhere (23). Our study detected runt-related tran-
scription factor 2 expression in vivo by immunofluorescence but found
no significant difference in expression levels between Biodentine and
MTA.
This study showed no significant differences in cell viability be-
tween MTA and Biodentine extracts, and both similarly induce SPP1,
ALPL, and RUNX2 gene expression. In vivo, Biodentine stimulated
similar mineralization markers as MTA, but staining was more intense
in root dental pulp and dentin bridges. Our findings suggest that Bio-
dentine could be advantageous in the long-term for conservative end-
odontic treatment to offset the high cost of the material. However,
further studies are needed to determine the exact role of each mineral-
ization protein and the signaling pathways that are activated to initiate
mineralized tissue formation.Acknowledgments
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